(The author is a Reuters Breakingviews columnist. The opinions
expressed are her own.)
By Carol Ryan
LONDON, Nov 6 (Reuters Breakingviews) - The KitKat maker is
selling a unit specialising in psoriasis and acne treatments.
Rival consumer groups may be put off by the business’s tricky
mix of products and low margins. Private equity firms, already
piling into the dermatology sector, would make a more logical
owner.
Full view will be published shortly.
On Twitter https://twitter.com/Breakingviews
CONTEXT NEWS
- Nestlé’s skin health division may attract bids from
Johnson & Johnson and private equity managers including KKR & Co
and Apax Partners, Bloomberg reported on Oct. 19 citing sources.
- The Swiss food group said on Sept. 20 that it would
conduct a review of strategic options for the business by
mid-2019.
- For previous columns by the author, Reuters customers can
click on RYAN/
- SIGN UP FOR BREAKINGVIEWS EMAIL ALERTS http://bit.ly/BVsubscribe
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Bloomberg article https://www.bloomberg.com/news/articles/2018-10-19/nestle-is-said-to-work-with-advisers-to-review-skin-health-unit
BREAKINGVIEWS-Unilever and Nestlé’s growth tests pricing power
urn:newsml:reuters.com:*:nL8N1WY24L
BREAKINGVIEWS-Nestlé has easier wins ahead in activist battle
urn:newsml:reuters.com:*:nL5N1UL66I
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
(Editing by Neil Unmack and Bob Cervi)
((carol.ryan@thomsonreuters.com; Reuters Messaging:
carol.ryan.thomsonreuters.com@reuters.net))